Anti-IL-23 exerted protective effects on cerebral ischemia–reperfusion injury through JAK2/STAT3 signaling pathway-Reference-Cited by-同舟云学术

Anti-IL-23 exerted protective effects on cerebral ischemia–reperfusion injury through JAK2/STAT3 signaling pathway

Published:2021-04 Issue:4 Volume:48 Page:3475-3484
ISSN:0301-4851
Container-title:Molecular Biology Reports
language:en
Short-container-title:Mol Biol Rep

Author:

Fan Lichao,Zhou Lichun^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s11033-021-06339-4.pdf

Reference50 articles.

1. Yu L et al (2018) Sedentary behavior and the risk of cardiac-cerebral vascular diseases in Southern China. Medicine 97:e12838

2. Fang Z et al (2017) Association study of IGFBP1 and IGFBP3 polymorphisms with hypertension and cardio-cerebral vascular diseases in a Chinese Han population. Oncotarget 8:77836

3. Xiao T, Palida K, Dan Y (2017) Luteolin protects brain injury and improves endogenous neural stem cells proliferation on cerebral ischemia-reperfusion injury in rat. Chin J Biochem Pharm 37:37–40

4. Hou Y et al (2018) Nrf2 inhibits NLRP3 inflammasome activation through regulating Trx1/TXNIP complex in cerebral ischemia reperfusion injury. Behav Brain Res 336:32–39

5. Chen C et al (2018) Platelet glycoprotein receptor Ib blockade ameliorates experimental cerebral ischemia–reperfusion injury by strengthening the blood–brain barrier function and anti-thrombo-inflammatory property. Brain Behav Immun 69:255–263

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of Different Therapeutic Approaches on Redox Balance in Psoriatic Patients;Biomedicines;2024-03-06

2. Interleukins in Epilepsy: Friend or Foe;Neuroscience Bulletin;2024-01-24

3. Th17 Cells and IL-17A in Ischemic Stroke;Molecular Neurobiology;2023-10-26

4. Effect of lipoxin A4 methyl ester from arachidonic acid on JAK2/STAT3 pathway after cerebral ischemia-reperfusion injury;Food Science and Technology;2023

5. Potential cerebrovascular accident signal for risankizumab: A disproportionality analysis of the FDA Adverse Event Reporting System (FAERS);British Journal of Clinical Pharmacology;2022-11-15